Perspectum Ltd
Perspectum, an Oxford University spin-out, develops AI-powered medical imaging and data-analysis tools. Its best-known product is LiverMultiScan, a non-invasive MRI-based assessment of liver disease, and it also covers metabolic disease, diabetes and cancer. It sells software and imaging services to clinicians and healthcare providers, and runs clinical-trial imaging services for pharma. It raised a $55M Series C led by Oppenheimer, closing in March 2023, and Tracxn estimates roughly $140M raised in total. Tracxn also puts 2024 revenue in the £10–50M range, and headcount is about 260–280 (2026).
Funding
Every round, secondary, debt facility or acquisition involving Perspectum Ltd that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in